Combination of Tissue-Plasminogen Activator With Erythropoietin Induces Blood-Brain Barrier Permeability, Extracellular Matrix Disaggregation, and DNA Fragmentation After Focal Cerebral Ischemia in Mice

被引:66
作者
Zechariah, Anil [1 ]
ElAli, Ayman [1 ]
Hermann, Dirk M. [1 ]
机构
[1] Univ Hosp Essen, Dept Neurol, D-45122 Essen, Germany
关键词
blood-brain barrier permeability; hematopoietic growth factor; neuroprotection; stroke; thrombolytic; NEUROPROTECTIVE ACTIVITY; PROTEIN-C; STROKE; INJURY; METALLOPROTEINASE; HEMORRHAGE; REPERFUSION; MORTALITY; THERAPY; DAMAGE;
D O I
10.1161/STROKEAHA.109.574418
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose-After 1 clinical study in which recombinant erythropoietin (EPO) protected against ischemic stroke and improved clinical outcome, the German multicenter EPO trial recently reported increased mortality in stroke patients receiving EPO after tissue-plasminogen activator (t-PA)-induced thrombolysis. The reasons for the adverse effects of EPO in t-PA-treated patients are unknown. Methods-Mice were submitted to 90 minutes of middle cerebral artery occlusion. Immediately after reperfusion, animals were treated with normal saline or t-PA (10 mg/kg). Animals subsequently received injections of normal saline or EPO that were administered after reperfusion and 12 hours later (2500 IU/kg each). Ischemic injury and brain edema were analyzed at 24 hours after reperfusion by cresyl violet staining and terminal transferase biotinylated-dUTP nick end labeling. Blood-brain barrier integrity was assessed by histochemistry for extravasated serum IgG. Matrix metalloproteinase activity was evaluated by gelatinase zymography. Results-EPO did not influence ischemic infarct size but reduced brain swelling. This effect was abolished by t-PA, which exacerbated serum IgG extravasation in ischemic tissue. Gelatinase zymographies revealed that EPO promoted matrix metalloproteinase-9 activity that was markedly elevated by t-PA. Add-on treatment with t-PA increased the density of DNA-fragmented cells in ischemic tissue of EPO-treated, but not vehicle-treated, mice. Conclusions-Our data demonstrate a hitherto unknown interaction of t-PA with EPO at the blood-brain interface, ie, promotion of vascular permeability and extracellular matrix breakdown, which may account for the unfavorable actions of EPO in t-PA-treated patients. After t-PA-induced thrombolysis, EPO may not be suitable as stroke treatment. (Stroke. 2010;41:1008-1012.)
引用
收藏
页码:1008 / 1012
页数:5
相关论文
共 31 条
  • [1] A potential role for erythropoietin in focal permanent cerebral ischemia in mice
    Bernaudin, M
    Marti, HH
    Roussel, S
    Divoux, D
    Nouvelot, A
    MacKenzie, E
    Petit, E
    [J]. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1999, 19 (06) : 643 - 651
  • [2] Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury
    Brines, ML
    Ghezzi, P
    Keenan, S
    Agnello, D
    de Lanerolle, NC
    Cerami, C
    Itri, LM
    Cerami, A
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (19) : 10526 - 10531
  • [3] rt-PA causes a dose-dependent increase in the extravasation of cellular and non-cellular blood elements after focal cerebral ischemia
    Burggraf, Dorothe
    Martens, Helge K.
    Dichgans, Martin
    Hamann, Gerhard F.
    [J]. BRAIN RESEARCH, 2007, 1164 : 55 - 62
  • [4] Activated protein C inhibits tissue plasminogen activator-induced brain hemorrhage
    Cheng, Tong
    Petraglia, Anthony L.
    Li, Zhang
    Thiyagarajan, Meenakshisundaram
    Zhong, Zhihui
    Wu, Zhenhua
    Liu, Dong
    Maggirwar, Sanjay B.
    Deane, Rashid
    Fernandez, Jose A.
    LaRue, Barbra
    Griffin, John H.
    Chopp, Michael
    Zlokovic, Berislav V.
    [J]. NATURE MEDICINE, 2006, 12 (11) : 1278 - 1285
  • [5] Erythropoietin therapy for acute stroke is both safe and beneficial
    Ehrenreich, H
    Hasselblatt, M
    Dembowski, C
    Cepek, L
    Lewczuk, P
    Stiefel, M
    Rustenbeck, HH
    Breiter, N
    Jacob, S
    Knerlich, F
    Bohn, M
    Poser, W
    Rüther, E
    Kochen, M
    Gefeller, O
    Gleiter, C
    Wessel, TC
    De Ryck, M
    Itri, L
    Prange, H
    Cerami, A
    Brines, M
    Sirén, AL
    [J]. MOLECULAR MEDICINE, 2002, 8 (08) : 495 - 505
  • [6] Recombinant Human Erythropoietin in the Treatment of Acute Ischemic Stroke
    Ehrenreich, Hannelore
    Weissenborn, Karin
    Prange, Hilmar
    Schneider, Dietmar
    Weimar, Christian
    Wartenberg, Katja
    Schellinger, Peter D.
    Bohn, Matthias
    Becker, Harald
    Wegrzyn, Martin
    Jaehnig, Peter
    Herrmann, Manfred
    Knauth, Michael
    Baehr, Mathias
    Heide, Wolfgang
    Wagner, Armin
    Schwab, Stefan
    Reichmann, Heinz
    Schwendemann, Guenther
    Dengler, Reinhard
    Kastrup, Andreas
    Bartels, Claudia
    [J]. STROKE, 2009, 40 (12) : E647 - E656
  • [7] Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo
    Erbayraktar, S
    Grasso, G
    Sfacteria, A
    Xie, QW
    Coleman, T
    Kreilgaard, M
    Torup, L
    Sager, T
    Erbayraktar, Z
    Gokmen, N
    Yilmaz, O
    Ghezzi, P
    Villa, P
    Fratelli, M
    Casagrande, S
    Leist, M
    Helboe, L
    Gerwein, J
    Christensen, S
    Geist, MA
    Pedersen, LO
    Cerami-Hand, C
    Wuerth, JP
    Cerami, A
    Brines, M
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (11) : 6741 - 6746
  • [8] Tissue plasminogen activator-induced reperfusion injury after stroke revisited
    Hermann, Dirk M.
    Matter, Christian M.
    [J]. CIRCULATION, 2007, 116 (04) : 363 - 365
  • [9] Brain-derived erythropoietin protects from focal cerebral ischemia by dual activation of ERK-1/-2 and Akt pathways
    Kilic, E
    Kilic, Ü
    Soliz, J
    Bassetti, CL
    Gassmann, M
    Hermann, DM
    [J]. FASEB JOURNAL, 2005, 19 (12) : 2026 - +
  • [10] Tissue-plasminogen activator-induced ischemic brain injury is reversed by melatonin:: role of iNOS and Akt
    Kilic, E
    Kilic, Ü
    Reiter, RJ
    Bassetti, CL
    Hermann, DM
    [J]. JOURNAL OF PINEAL RESEARCH, 2005, 39 (02) : 151 - 155